Abstract
Dear Editor,
Recent advances in understanding the complex pathogenesis of atopic dermatitis (AD, also known as eczema or atopic eczema), coupled with the development of new treatments, have led to increased interest from multiple stakeholders. There is a need to prioritize areas for research to inform a coordinated approach to advancing science and patient care. We sought to fill a gap in the literature, specifically from the perspective of clinicians involved in AD patient care and research.
Our objective was to identify and reach consensus on a set of research questions to be prioritized for future work in AD. We conducted a three‐round electronic Delphi (eDelphi) process with members of the International Eczema Council (IEC). The IEC is a global nonprofit organization that aims to promote the optimal management of AD through research, education and patient/family care.
[...]
Recent advances in understanding the complex pathogenesis of atopic dermatitis (AD, also known as eczema or atopic eczema), coupled with the development of new treatments, have led to increased interest from multiple stakeholders. There is a need to prioritize areas for research to inform a coordinated approach to advancing science and patient care. We sought to fill a gap in the literature, specifically from the perspective of clinicians involved in AD patient care and research.
Our objective was to identify and reach consensus on a set of research questions to be prioritized for future work in AD. We conducted a three‐round electronic Delphi (eDelphi) process with members of the International Eczema Council (IEC). The IEC is a global nonprofit organization that aims to promote the optimal management of AD through research, education and patient/family care.
[...]
Original language | English |
---|---|
Pages (from-to) | 203-205 |
Number of pages | 3 |
Journal | British Journal of Dermatology |
Volume | 185 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Jul 2021 |